Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Engineering
Biomanufacturing Of Micro-Myocardial Tissue Through Suspension Differentiation With Improved Yields, Purity, And Quality, Asher M. Kahn-Krell
Biomanufacturing Of Micro-Myocardial Tissue Through Suspension Differentiation With Improved Yields, Purity, And Quality, Asher M. Kahn-Krell
All ETDs from UAB
Despite major advances in revascularization and drug therapy for post-myocardial infarction (MI) heart failure (HF), heart transplantation remains the only curative therapy to prevent progressive and debilitating disease. Researchers have long sought a replenishable and expandable source of cardiomyocytes (CMs), the primary functional cell in the heart muscle, for a broad array of applications related to the treatment of HF ranging from direct implantation to high throughput drug testing. The lack of cell cycle activity and cell division in adult CMs prevented the development of an expandable primary cell line. However, with the discovery of high efficiency stem cell differentiation …
An Ex Vivo Model Of Neuroendocrine Tumors: A Net Gain, Brendon R. Herring
An Ex Vivo Model Of Neuroendocrine Tumors: A Net Gain, Brendon R. Herring
All ETDs from UAB
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that originate in a diverse array of anatomical locations and have widely variable clinical presentations and responses to treatment. Patient-derived xenografts and cell lines are valuable models of tumor biology and for testing personalized therapeutics on tumors prior to their administration to patients. However, as PDX models and cell lines for neuroendocrine tumors are lacking in both number and validity, we have developed a 3D flow perfusion polydimethylsiloxane (PDMS) bioreactor model for the purpose of culturing patient derived NETs. The goal of this thesis is to determine the ability to use …
A Three Dimensional Microphysiologic Liver Model For Toxicity Testing, Lindsay Mckinney Miller
A Three Dimensional Microphysiologic Liver Model For Toxicity Testing, Lindsay Mckinney Miller
All ETDs from UAB
Drug development is an expensive and time consuming process, requiring an average of over $1 billion and up to fifteen years of work for each newly released product. Drug-induced liver toxicity is the leading cause of post-market drug withdrawals despite the fact that extensive animal testing and clinical trials are required prior to approval of a novel drug or therapy. Due to both the specificity and genetic variability of hepatic regulation and metabolism in humans, animal models and single-cell hepatocyte testing cannot fully predict the metabolic response of a novel compound. In vitro organ culture in a three dimensional (3D) …
Utilizing A Hydroxyapatite-Binding Domain To Deliver Bone Regenerative Molecules To Hydroxyapatite And Allograft Bone To Enhance Osteogenesis, Bonnie Kathleen Culpepper
Utilizing A Hydroxyapatite-Binding Domain To Deliver Bone Regenerative Molecules To Hydroxyapatite And Allograft Bone To Enhance Osteogenesis, Bonnie Kathleen Culpepper
All ETDs from UAB
Hydroxyapatite (HA) makes up the mineral component of bone, and synthetic HA is commonly used to coat metal implants for use in dentistry and orthopedics. Additionally, allograft and synthetic HA are common alternatives to autograft bone, to circumvent the complications associated with a second surgery site. While both HA and allograft are known to be osteoconductive, osteoinductivity is limited. In this work, we developed methods for anchoring osteoinductive factors onto multiple types of HA biomaterials and human allograft bone, with the goal of enhancing their osteoregenerative potential. Specifically, a HA-binding domain, heptaglutamate (E7), modeled on bone-binding domains within native proteins, …